X4 Pharmaceuticals, Inc. XFOR
3.35 USD +0.17 (+5.35%)
Nov 9, 2026, 2:53 PM EST
3.18 Day range 3.45
2.43 52-week range 4.83
- YTD
- -16.25%
- 1 year
- -9.70%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 35.11M | 2.56M | 0 | 0 | 0 | |
| 29.36M | 1.76M | 0 | 0 | 0 | |
| -86.88M | -36.40M | -107.52M | -87.57M | -85.11M | |
| -79.20M | -37.45M | -101.17M | -93.87M | -88.70M | |
| -1.87 | -5.59 | -17.07 | -45.60 | -120.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 217.05M | 55.70M | 99.22M | 121.72M | 81.79M | |
| 290.46M | 146.45M | 147.26M | 155.59M | 117.18M | |
| 104.17M | 124.30M | 96.16M | 81.53M | 52.76M | |
| 77.28M | 78.09M | 58.28M | 38.42M | 39.78M | |
| 186.29M | 22.15M | 51.10M | 74.05M | 64.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -85.62M | -130.90M | -96.51M | -77.10M | -70.91M | |
| 8.15M | 66.99M | -14.88M | -103.00K | -615.00K | |
| 238.63M | 20.29M | 88.52M | 117.23M | 74.25M | |
| -3.00M | -7.33M | -60.00K | -103.00K | -615.00K | |
| 161.38M | -43.77M | -22.78M | 39.92M | 2.41M |